H. B. Fuller/$FUL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About H. B. Fuller

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

Ticker

$FUL
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

7,500

ISIN

US3596941068

H. B. Fuller Metrics

BasicAdvanced
$3.5B
34.84
$1.84
1.12
$0.90
1.47%

What the Analysts think about H. B. Fuller

Analyst ratings (Buy, Hold, Sell) for H. B. Fuller stock.

Bulls say / Bears say

H.B. Fuller reported adjusted earnings per share of $1.18 for the quarter ended May 31, 2025, surpassing analyst expectations of $1.08, indicating strong operational performance. (reuters.com)
The company increased its quarterly dividend by 5.6% to $0.2350 per share, reflecting confidence in its financial health and commitment to returning value to shareholders. (reuters.com)
Despite a 2.7% decline in net revenue for the quarter ended February 28, 2025, H.B. Fuller achieved an organic revenue increase of 1.9% year-over-year, driven by improved volume, suggesting resilience in its core business. (reuters.com)
JP Morgan downgraded H.B. Fuller's price target from $60 to $50, citing weak performance in the Health, Hygiene, and Consumable segment and projecting only about 1% adjusted EBITDA growth for FY2025. (benzinga.com)
In the third quarter of 2024, H.B. Fuller missed analyst expectations, with revenue falling short by 2.8% and EPS missing estimates by 11%, raising concerns about its ability to meet market forecasts. (simplywall.st)
Citigroup lowered its price objective for H.B. Fuller from $78.00 to $68.00, maintaining a 'neutral' rating, reflecting a cautious outlook on the company's stock performance. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.

H. B. Fuller Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

H. B. Fuller Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $FUL

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs